Evropská unie - čeština - EMA (European Medicines Agency)

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresiva - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

neuraxpharm bohemia s.r.o., praha array - 10905 zolpidem-tartarÁt - potahovaná tableta - 10mg - zolpidem